Implementing magnetic resonance imaging into clinical routine screening in patients with psychosis?
-
Borgwardt S
Stefan Borgwardt, MD, MBA, Head of Neuropsychiatry and Brain Imaging, Department of Psychiatry, University of Basel, Switzerland; André Schmidt, MSc, PhD, Research Group Leader in the Department of Psychiatry (UPK), University of Basel, Switzerland Stefan.borgwardt@upkbs.ch.
-
Schmidt A
Stefan Borgwardt, MD, MBA, Head of Neuropsychiatry and Brain Imaging, Department of Psychiatry, University of Basel, Switzerland; André Schmidt, MSc, PhD, Research Group Leader in the Department of Psychiatry (UPK), University of Basel, Switzerland.
Published in:
- The British journal of psychiatry : the journal of mental science. - 2017
English
In this issue, Falkenberg et al explore the practicability of magnetic resonance imaging (MRI) as part of the initial clinical assessment in patients with first-episode psychosis and the prevalence, nature and clinical significance of radiological abnormalities in these patients. They provide evidence for the use of MRI data to detect gross brain abnormalities. In addition, improvements in quantitative analyses makes MRI an indispensable tool to elucidate the neurobiological substrates that might underlie primary (or idiopathic) psychotic illness.
-
Language
-
-
Open access status
-
bronze
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/global/documents/160333
Statistics
Document views: 12
File downloads: